Related Experiment Video
Updated: May 9, 2025

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
Published on: May 13, 2022
Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study
Jerome Sepin1,2, Thomas P A Debray3,4, Wei Wei1
1Biogen International GmbH, Baar, Switzerland.
The principal stratum strategy offers a robust method for estimating causal treatment effects in specific patient groups, particularly when dealing with intercurrent events like anti-drug antibodies in biosimilar trials. This approach addresses biases inherent in traditional subgroup analyses.
Area of Science:
- Biostatistics
- Clinical Trial Methodology
- Pharmacovigilance
Background:
- The ICH E9 (R1) Addendum introduced the estimand framework to refine research questions in clinical trials.
- Intercurrent events (ICE) require specific strategies for accurate treatment effect estimation.
- Traditional subgroup analyses based on post-randomization variables like immunogenicity can introduce bias.
Purpose of the Study:
- To examine the principal stratum strategy for estimating causal treatment effects in specific subpopulations.
- To address the challenges of using post-randomization variables, such as anti-drug antibodies (ADAs), as intercurrent events.
- To demonstrate the implementation of the principal stratum strategy in a biosimilar trial.
Main Methods:
- Utilized the principal stratum strategy, leveraging counterfactuals and a missing data perspective.
- Applied a multiple imputation approach with longitudinal measurements.
- Implemented the strategy in a Phase 3 equivalence trial for a rheumatoid arthritis biosimilar.
Main Results:
- The principal stratum strategy enables estimation of treatment effects in subpopulations defined by intercurrent events.
- Demonstrated a method to create analysis datasets for subpopulations with ADAs as ICE.
- Highlighted the strategy's reliance on unobserved states and the need for complex modeling.
Conclusions:
- The principal stratum strategy provides a statistically sound pathway for estimating causal effects in specific subpopulations affected by intercurrent events.
- This method offers an alternative to biased subgroup analyses for variables like immunogenicity.
- Successful implementation requires rigorous modeling and careful consideration of assumptions regarding unobserved states.
Related Concept Videos
Blinding
Trial and Error and Algorithm
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Blind Procedures
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Case Studies

